Clinical Indication

KCNT1 gene mutation related Early Infantile Epileptic Encephalopathy


Reviewed by TAS September 2021

Date of classification

October 2021

Review date

October 2021


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.